Answers
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > Outperform the Market - Everytime!

Tags

  • individual
  • information
  • still
  • developing combination
  • developing combination
  • market trends

  • Links

  • Make Profits from Arena Football
  • Acceptance as a Path to Inner Peace
  • Mastoiditis - Definition, Causes, Symptoms and Treatment
  • Answers - Outperform the Market - Everytime!

    Are you looking to outperform the market and optimize your profits but are not sure how to pick the right stocks? Has investing become a chore? Do you find yourself
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    investing in hot stocks after they have made their big move?


    Do You Hate Research? . . . I do!


    I have always wanted to find an investment strategy that mad
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    e sense. An investment strategy in which I do not need to know the intricacies of the market, predict market trends or follow specific stocks. How can I get the ins
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    de information of what is hot before the rest of the market knows? I can't. Nor do I need to. Plus, I don't have that kind of time to commit to in-depth research.
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    Like you, I have a regular job that I need to devote my time to. I am not a day trader; nor do I want to spend all of my free time on the computer doing research. A
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ways following the stock market and getting stock quotes is not how I want to spend my free time.


    I Avoid Individual Stocks . . . they are too unreliable!


    E
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    verybody wants to buy low and sell high. While millions of people do make money this way (and many millions loose money), I have found an easier and more effective wa
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    y to use the market to my advantage. I do not trade in stocks. I do what I can to avoid individual stocks. And I consistently beat the market . . . month after mont
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    after month.


    If not stocks, what's the alternative?


    Like many people, I got heavily involved in the stock market in the mid to late Nineties. Tech stocks
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    were going through the roof and I, like everybody else, wanted a part of the action. It seemed an easy way to make money. Everybody was getting rich. You did not n
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ed a special investment strategy to beat the market.


    During this time, I engrossed myself in the financial markets. I wanted to learn as much as I could without
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    giving up my day job. I was trying to find the next best tech stock, IPOs and the occasional pre-IPO offering. But it was not until I discovered options trading th
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    at I discovered an investment strategy (The Yager Trading Strategy) that can work in any kind of market . . . Bull, Bear or stagnant.


    That's right...OPTION tradi
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    g!


    And I am not talking about stock options or writing covered calls. Options trading...I started selling options on S&P futures, using different methods and tra
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ding strategies. And I did well. VERY well.


    Between July 1998 and January 2000 (a span of 18 months), from my option trading system, I turned an initial $25,000
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    investment into $167,615. That's over 670% increase. And this was not paper money where you buy a stock and it has a certain listed value. This was real, taxed inc
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ome. Profits collected on a monthly basis.


    Market fluctuations and volatility have diminished greatly since then...reducing the premiums. Those types of return
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    s are no longer available, but the option trading strategy is still very sound. I still consistently beat the market. Even the years the DJIA, Nasdaq and S&P were a
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    l down, I posted more than a 22% gain.


    Learn the option trading strategy or see how to make money with this strategy. I descriibe the strategy and show actual re
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    cent trades on www.yagerinvesting.com. The information is FREE. No subscription required. This is a method for risk capital only.


    http://www.yagerinvesting.co


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.answers.org.ua/article/102154/answers-Outperform-the-Market--Everytime.html">Outperform the Market - Everytime!</a>

    BB link (for phorums):
    [url=http://www.answers.org.ua/article/102154/answers-Outperform-the-Market--Everytime.html]Outperform the Market - Everytime![/url]

    Related Articles:

    Jobs To Do Online - A Dream Come True

    Listen More & Talk Less: 7 Steps to Avoiding Obvious Mistakes

    Multi-Level Marketing is Dead - Killed By The Internet

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com